Frequency (%) | |
---|---|
Antipscyhotic medication | |
Second generation antipsychotics | |
Yes | 60 (50.0%) |
No | 60 (50.0%) |
First generation antipsychotics | |
Yes | 92 (76.7%) |
No | 28 (23.3%) |
Mood stabilizer medications (Lithium family group and antiepileptic medications) | |
Yes | 65 (36.1%) |
No | 115 (63.9%) |
Lithium carbonate | |
Yes | 16 (13.3%) |
No | 104 (86.7%) |
Antiepileptics | |
Yes | 58 (48.3%) |
No | 62 (51.7%) |
Benzodiazepines | |
Yes | 45 (37.5%) |
No | 75 (62.5%) |
Anticholinergics | |
Yes | 85 (70.8%) |
No | 35 (29.2%) |
Antidepressants medications | |
Yes | 15 (8.3%) |
No | 165 (91.7%) |
Tricyclic antidepressants | |
Yes | 9 (7.5%) |
No | 111 (92.5%) |
Other antidepressants | |
Yes | 6 (5.0%) |
No | 114 (95.0%) |
Other types of medications* | |
Yes | 61 (50.8%) |
No | 59 (49.2%) |
Mean ± SD | |
Chlorpromazine equivalent dose | 1041.6 [Min .5; Max 4502.0] |
Benzodiazepine (Valium) equivalent dose | 15.03 [Min 5.00; Max 48.00] |
Anticholinergic Drug Scale (ADS) | 7.18 ± 3.11 |
Duration of medication treatment (in months) | 54.7 ± 29.5 |
Number of antipsychotics used | 1.85 ± 0.94 |